A. S. Kumar and V. Samuel, “Cost-Effectiveness of Co-Amoxiclav Versus Clindamycinin the Treatment of Uncomplicated Soft Tissue Infections in a Tertiary Care Hospital”, health, vol. 1, no. 1, pp. 15–22, Mar. 2025.